Four actresses including Bhavana quit male-dominated AMMA after Dileep’s reinstatement

Haveri, Jan 16: Karnataka Chief Minister B S Yediyurappa on Wednesday hinted at inducting 16 MLAs into the Cabinet which was due for expansion despite the fact that it was a difficult task.

Participating in a function of Choudayya Community here, he further said one should understand the difficulty faced to undertake cabinet expansion in the prevailing situation and whoever gives suggestion should understand the circumstances otherwise the statements would lead to confusion among the community and people of the state.

He stated that 'as many as 17 MLAs resigned to make me Chief Minister and now their community people want their leader to become Minister, it is very difficult to satisfy all of them'.

Mangaluru, June 27: The district health authorities are likely to conduct mass random testing for Covid-19 in Ullal town on the outskirts of the city in the wake of detection of several new coronavirus positive cases there in past couple few days.  

An elderly woman from Azad Nagar in Ullal was died of coronavirus earlier this week. Many others including a couple of policemen also tested positive for the deadly virus in vicinity.

Following this, local elected representatives including MLA U T Khader and religious leaders of Ullal held a meeting regarding taking steps to control the spread of the virus. In the meeting Mr Khader suggested the authorities to conduct random testing in Ullal town. 

Apart from Azad Nagar, covid-19 cases have surfaced in Kodi, Bangera Lane and in the surroundings of police station and Sahara Hospital triggering panic among people. Hence, the authorities are like to conduct random testing of auto rickshaw drivers, fishermen, street vendors among others. 

Meanwhile, several mosques in Ullal have reportedly decided to suspend congregational prayers temporarily.

The United States of America has bought almost the entire world's supply of remdesivir, one of just two drugs proven to treat COVID-19. 

“President Trump has struck an amazing deal to ensure Americans have access to the first authorised therapeutic for Covid-19,” said the US health and human services secretary, Alex Azar. 

“To the extent possible, we want to ensure that any American patient who needs remdesivir can get it. The Trump administration is doing everything in our power to learn more about life-saving therapeutics for Covid-19 and secure access to these options for the American people.”

The announcement implies that no other country in the world will be able to buy remdesivir for next three months at least.

The anti-viral drug patented by the US-based Gilead biotech firm is the only one approved by the European Medicines Agency (EMA) to treat patients with the novel coronavirus.

The Trump administration has already shown that it is prepared to outbid and outmanoeuvre all other countries to secure the medical supplies it needs for the US.

“They’ve got access to most of the drug supply [of remdesivir], so there’s nothing for Europe,” said Dr Andrew Hill, senior visiting research fellow at Liverpool University.

Remdesivir, the first drug approved by licensing authorities in the US to treat Covid-19, is made by Gilead and has been shown to help people recover faster from the disease. 

The first 140,000 doses, supplied to drug trials around the world, have been used up. The Trump administration has now bought more than 500,000 doses, which is all of Gilead’s production for July and 90% of August and September.